Kevin C.J. Yuen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care

Kevin C.J. Yuen, Beverly M. K. Biller, Sally Radovick et al. · Endocrine Practice · 2019 · 287 citations

Medicine, Endocrinology, Pediatrics +15

Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes

Jessica R. Castle, J. Michael Engle, Joseph El Youssef et al. · Diabetes Care · 2010 · 230 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-Deficient Adults and Transition Patients – 2009 Update

David M. Cook, Kevin C.J. Yuen, Beverly M. K. Biller et al. · Endocrine Practice · 2009 · 180 citations

Medicine, Endocrinology, Internal Medicine +15